Prosperity Consulting Group, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1910398 OWINGS MILLS, MD

Position in GILD

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$3,387,428

-$464,898 QoQ

Shares Held

26,812

-3.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.34%

of 13F equity value

Holder Rank

#681

of 2,266 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Prosperity Consulting Group, LLC holds $39,098,306 across 13 Drug Manufacturers - General names. GILD ranks #5 (8.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	11,223	$13,461,204
2	ABBV	AbbVie Inc.	27,908	$7,022,769
3	JNJ	Johnson & Johnson	22,450	$5,701,626
4	MRK	Merck & Co., Inc.	27,182	$3,492,887
5	GILD	Gilead Sciences, Inc. This page	26,812	$3,387,428
6	GSK	GSK plc	31,262	$1,638,754
7	PFE	Pfizer Inc	44,889	$1,080,927
8	AZN	Astrazeneca PLC	4,762	$902,970

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,387,428	26,812	-3.0%	Shares	Sole	2026-08-13
2026-03-31	$3,852,326	27,641	-5.2%	Shares	Sole	2026-05-05
2025-12-31	$3,579,834	29,166	+1.1%	Shares	Sole	2026-02-17
2025-09-30	$3,201,795	28,845	-1.9%	Shares	Sole	2025-11-14
2025-06-30	$3,260,021	29,404	+16.2%	Shares	Sole	2025-08-05
2025-03-31	$2,834,528	25,297	-5.6%	Shares	Sole	2025-05-07
2024-12-31	$2,475,238	26,797	-6.2%	Shares	Sole	2025-02-14
2024-09-30	$2,394,805	28,564	-21.5%	Shares	Sole	2024-10-15
2024-06-30	$2,495,345	36,370	-31.4%	Shares	Sole	2024-08-08
2024-03-31	$3,881,151	52,985	+1175.8%	Shares	Sole	2024-05-01
2023-12-31	$336,434	4,153	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.